How to reconstitute peptides, and when you should not have to.

Why peptides need reconstitution at all

Most therapeutic peptides are shipped from the manufacturer in lyophilized (freeze-dried) form because the dry powder is far more stable than the same peptide in solution. A lyophilized vial held under refrigeration can remain potent for months to years. Once the peptide is dissolved in water, hydrolysis and oxidation start degrading the molecule, so the in-use shelf life drops to weeks.

This is why pharmacy compounding workflows and research-peptide vendors both ship lyophilized vials by default. The end user historically performs the reconstitution at the time of first use to maximize the active peptide window. The procedure is well-defined and not difficult to perform correctly, but it does require sterile technique, the right diluent, and the right ratio.

The reconstitution procedure

The standard procedure uses bacteriostatic water for injection (sterile water with 0.9 percent benzyl alcohol as a preservative) rather than plain sterile water. The benzyl alcohol prevents microbial growth across multiple punctures of the same vial, which matters because most reconstituted peptides are dosed over 14 to 28 days from a multi-dose vial.

1. Wash hands and prepare a clean surface. Wash hands thoroughly with soap and water, dry, and lay out the peptide vial, bacteriostatic water, syringe, and alcohol pads on a clean flat surface.
2. Sanitize the rubber stoppers. Wipe the rubber stopper of both the bacteriostatic water vial and the peptide vial with a fresh alcohol pad and let air dry for 10 to 15 seconds.
3. Draw the bacteriostatic water. Pull back the syringe plunger to draw air equal to the target reconstitution volume (typically 1 to 5 mL). Insert the needle into the bacteriostatic water vial, push the air in, invert, and slowly draw the target volume of water back into the syringe.
4. Inject the water down the side of the peptide vial. Insert the needle into the peptide vial at an angle so the water runs down the inner wall rather than spraying directly onto the lyophilized cake. Direct spray can shear the peptide and reduce potency.
5. Swirl, do not shake. Roll the vial gently between your palms or swirl in slow circles for 30 to 60 seconds. Shaking creates foam and can denature the peptide. Continue until the powder is fully dissolved and the solution is clear.
6. Refrigerate and label. Refrigerate the reconstituted vial at 36 to 46 degrees Fahrenheit. Label the vial with the reconstitution date, the concentration in mg per mL, and the in-use Beyond Use Date (typically 28 days for most peptides reconstituted with bacteriostatic water).

Common mistakes to avoid

• Shaking the vial. Vigorous shaking creates foam and shear forces that can denature the peptide. Always swirl.
• Using sterile water without preservative. Plain sterile water cannot prevent microbial growth across multiple punctures and shortens the in-use BUD to less than 24 hours.
• Spraying the cake directly. Hitting the dry peptide cake with a high-pressure stream can fragment the molecule and reduce active recovery.
• Storing at room temperature. Reconstituted peptides degrade quickly above refrigerator temperature. Always refrigerate. Do not freeze.
• Reusing draw syringes for injection. Use a fresh sterile insulin syringe for each injection drawn from the multi-dose vial.

Storage and the in-use Beyond Use Date

The Beyond Use Date (BUD) of a reconstituted peptide depends on the diluent, the storage temperature, and the specific peptide. As a general rule, peptides reconstituted with bacteriostatic water and held at refrigerator temperature carry an in-use BUD of 28 days. Peptides reconstituted with plain sterile water (no preservative) have a BUD of 24 hours or less. Once the BUD passes, the vial should be discarded even if it appears clear and unused, because potency cannot be guaranteed.

The bacteriostatic water shortage

Bacteriostatic water for injection has been on an active national shortage list maintained by the American Society of Health-System Pharmacists (ASHP) since 2023. Pfizer, through its Hospira subsidiary, is the dominant U.S. supplier of the 30 mL multi-dose vial that compounding pharmacies and end users rely on. The shortage was driven by manufacturing delays at Hospira combined with a sharp increase in demand from compounded GLP-1 prescribing.

As of July 2025, Pfizer further restricted distribution of Hospira bacteriostatic water to buyers with a DEA license or NPI on file, which effectively closed the gray-market supply route that research-peptide consumers had relied on. The FDA tracks the related sterile-water-for-injection shortage on its drug-shortage database.

Why most PeptideRx patients never reconstitute

Every peptide dispensed by Optimal Balance Pharmacy for PeptideRx prescriptions ships pre-reconstituted and ready to inject. The pharmacy compounds the active peptide and the diluent in a USP <797>-compliant sterile cleanroom, tests every batch through Eagle Analytical Services for sterility (ScanRDI or Celsis) and bacterial endotoxin (USP <85>), and ships the finished sterile solution in cold-chain packaging. Sterile insulin syringes and alcohol swabs are included.

The patient never has to source bacteriostatic water, never has to calculate concentration, never has to time the procedure, and never carries the contamination risk of a manual reconstitution. This is a structural difference from research-peptide vendors, who ship lyophilized powder that requires the buyer to mix it themselves.

Bottom line

Reconstitution is a real procedure with real consequences for potency and sterility. If you are working with a research-grade lyophilized peptide, the steps above are the correct technique, and the ASHP and FDA shortage notices are worth reading before assuming you can buy bacteriostatic water at will. If you are a PeptideRx patient, the procedure does not apply to you; your peptides arrive ready to draw and inject.

Start a $39 visit→